Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT04999631
EARLY_PHASE1
SADBE for Congenital Melanocytic Nevi
Sponsor: Massachusetts General Hospital
View on ClinicalTrials.gov
Summary
A study to evaluate the safety and efficacy topical squaric acid dibutylester (SADBE) for the neoadjuvant treatment of congenital melanocytic nevi (CMN).
Official title: Neoadjuvant Squaric Acid Dibutylester Treatment of Melanocytes in Congenital Melanocytic Nevi
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2022-01-01
Completion Date
2028-01-01
Last Updated
2021-10-28
Healthy Volunteers
No
Conditions
Interventions
DRUG
Squaric Acid Dibutyl Ester
Topical squaric acid dibutyl ester (SADBE) dissolved in ethanol at 0.2% concentration.
DRUG
Ethanol Solution
Control